 The design of dental implants is a subject of continuous improvement, and implant manufacturers regularly introduce new products the use of which may result in accelerated soft and hard tissue healing, increased initial implant stability, and enhanced esthetic outcomes. The purpose of this randomized, controlled trial is to compare treatment outcomes when using a newly-introduced dental implant NobelParallelTM CC in a one-stage or a two-stage protocol. This new implant has the same titanium oxide surface coating TiUnite and the same design principles of the parallel-walled NobelSpeedy GroovyTM implants, and an internal conical connection. The implant is marketed under the premarket notifications K050406 and K073142 510k, Food and Drug Administration. 